Texas 2015 - 84th Regular

Texas House Bill HB1424 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	84R8422 JSC-F
2		-	By: Lozano H.B. No. 1424
	1	+	H.B. No. 1424
3	2
4	3
5		-	A BILL TO BE ENTITLED
6	4		AN ACT
7		-	relating to the designation of certain synthetic compounds to
8		-	Penalty Group 2 or 2-A of the Texas Controlled Substances Act;
9		-	increasing penalties for certain persons convicted of the
10		-	manufacture and delivery of controlled substances.
	5	+	relating to increasing penalties for defendants convicted of the
	6	+	manufacture or delivery of certain controlled substances.
11	7		BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
12		-	SECTION 1. Sections 481.002(5) and (6), Health and Safety
13		-	Code, are amended to read as follows:
14		-	(5) "Controlled substance" means a substance,
15		-	including a drug, an adulterant, and a dilutant, listed in
16		-	Schedules I through V or Penalty Group [Groups] 1, 1-A, [or] 2, 2-A,
17		-	3, or [through] 4. The term includes the aggregate weight of any
18		-	mixture, solution, or other substance containing a controlled
19		-	substance.
20		-	(6) "Controlled substance analogue" means:
21		-	(A) a substance with a chemical structure
22		-	substantially similar to the chemical structure of a controlled
23		-	substance in Schedule I or II or Penalty Group 1, 1-A, [or] 2, or
24		-	2-A; or
25		-	(B) a substance specifically designed to produce
26		-	an effect substantially similar to, or greater than, the effect of a
27		-	controlled substance in Schedule I or II or Penalty Group 1, 1-A,
28		-	[or] 2, or 2-A.
29		-	SECTION 2. Section 481.103(a), Health and Safety Code, is
30		-	amended to read as follows:
31		-	(a) Penalty Group 2 consists of:
32		-	(1) any quantity of the following hallucinogenic
33		-	substances, their salts, isomers, and salts of isomers, unless
34		-	specifically excepted, if the existence of these salts, isomers,
35		-	and salts of isomers is possible within the specific chemical
36		-	designation:
37		-	alpha-ethyltryptamine;
38		-	alpha-methyltryptamine;
39		-	5-(2-aminopropyl)benzofuran (5-APB);
40		-	6-(2-aminopropyl)benzofuran (6-APB);
41		-	5-(2-aminopropyl)-2,3-dihydrobenzofuran
42		-	(5-APDB);
43		-	6-(2-aminopropyl)-2,3-dihydrobenzofuran
44		-	(6-APDB);
45		-	5-(2-aminopropyl)indole (Trade or other names:
46		-	5-IT, 5-API);
47		-	6-(2-aminopropyl)indole (Trade or other names:
48		-	6-IT, 6-API);
49		-	Benzothiophenylcyclohexylpiperidine (BTCP);
50		-	4-bromo-2, 5-dimethoxyamphetamine (some trade or
51		-	other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
52		-	4-bromo-2, 5-DMA);
53		-	4-bromo-2, 5-dimethoxyphenethylamine;
54		-	8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
55		-	4-ethanamine (Trade or other name: Bromo-DragonFLY);
56		-	Bufotenine (some trade and other names: 3-(beta-
57		-	Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5-
58		-	indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-
59		-	dimethyltryptamine; mappine);
60		-	Desoxypipradrol (2-benzhydrylpiperidine);
61		-	Diethyltryptamine (some trade and other names: N,
62		-	N-Diethyltryptamine, DET);
63		-	2, 5-dimethoxyamphetamine (some trade or other
64		-	names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
65		-	2, 5-dimethoxy-4-ethylamphetamine (trade or other
66		-	name: DOET);
67		-	2, 5-dimethoxy-4-(n)-propylthiophenethylamine
68		-	(trade or other name: 2C-T-7);
69		-	Dimethyltryptamine (trade or other name: DMT);
70		-	Diphenylprolinol (diphenyl(pyrrolidin-2-yl)
71		-	methanol, D2PM);
72		-	Dronabinol (synthetic) in sesame oil and
73		-	encapsulated in a soft gelatin capsule in a U.S. Food and Drug
74		-	Administration approved drug product (some trade or other names for
75		-	Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
76		-	trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
77		-	(trans)- tetrahydrocannabinol);
78		-	Ethylamine Analog of Phencyclidine (some trade or
79		-	other names: N-ethyl-1-phenylcyclohexylamine, (1-
80		-	phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
81		-	cyclohexamine, PCE);
82		-	2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
83		-	(Trade or other name: methoxetamine);
84		-	Ibogaine (some trade or other names: 7-Ethyl-6,
85		-	6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
86		-	pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
87		-	5-iodo-2-aminoindane (5-IAI);
88		-	Mescaline;
89		-	5-methoxy-N, N-diisopropyltryptamine
90		-	(5-MeO-DIPT);
91		-	5-methoxy-N, N-diallyltryptamine (5MeO-DALT);
92		-	5-methoxy-3, 4-methylenedioxy amphetamine;
93		-	4-methoxyamphetamine (some trade or other names:
94		-	4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine;
95		-	PMA);
96		-	4-methoxymethamphetamine (PMMA);
97		-	2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone
98		-	(Trade or other names: 2-MeO-ketamine; methoxyketamine);
99		-	1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
100		-	PPMP);
101		-	4-methyl-2, 5-dimethoxyamphetamine (some trade
102		-	and other names: 4-methyl-2, 5-dimethoxy-alpha-
103		-	methylphenethylamine; "DOM"; "STP");
104		-	3,4-methylenedioxy methamphetamine (MDMA, MDM);
105		-	3,4-methylenedioxy amphetamine;
106		-	3,4-methylenedioxy N-ethylamphetamine (Also
107		-	known as N-ethyl MDA);
108		-	5,6-methylenedioxy-2-aminoindane (MDAI);
109		-	Nabilone (Another name for nabilone: (+)-trans-
110		-	3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
111		-	6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
112		-	N-benzylpiperazine (some trade or other names:
113		-	BZP; 1-benzylpiperazine);
114		-	N-ethyl-3-piperidyl benzilate;
115		-	N-hydroxy-3,4-methylenedioxyamphetamine (Also
116		-	known as N-hydroxy MDA);
117		-	4-methylaminorex;
118		-	N-methyl-3-piperidyl benzilate;
119		-	O-Acetylpsilocin (Trade or other name:
120		-	4-Aco-DMT);
121		-	Parahexyl (some trade or other names: 3-Hexyl-1-
122		-	hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
123		-	pyran; Synhexyl);
124		-	1-Phenylcyclohexylamine;
125		-	1-Piperidinocyclohexanecarbonitrile (PCC);
126		-	Psilocin;
127		-	Psilocybin;
128		-	Pyrrolidine Analog of Phencyclidine (some trade
129		-	or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
130		-	Tetrahydrocannabinols, other than marihuana, and
131		-	synthetic equivalents of the substances contained in the plant, or
132		-	in the resinous extractives of Cannabis, or synthetic substances,
133		-	derivatives, and their isomers with similar chemical structure and
134		-	pharmacological activity such as:
135		-	delta-1 cis or trans tetrahydrocannabinol,
136		-	and their optical isomers;
137		-	delta-6 cis or trans tetrahydrocannabinol,
138		-	and their optical isomers;
139		-	delta-3, 4 cis or trans
140		-	tetrahydrocannabinol, and its optical isomers;
141		-	compounds of these structures, regardless of
142		-	numerical designation of atomic positions, since nomenclature of
143		-	these substances is not internationally standardized;
144		-	Thiophene Analog of Phencyclidine (some trade or
145		-	other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
146		-	Analog of Phencyclidine; TPCP, TCP);
147		-	1-pyrrolidine (some trade or other name: TCPy);
148		-	1-(3-trifluoromethylphenyl)piperazine (trade or
149		-	other name: TFMPP); and
150		-	3,4,5-trimethoxy amphetamine;
151		-	(2) Phenylacetone (some trade or other names:
152		-	Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
153		-	ketone);
154		-	(3) unless specifically excepted or unless listed in
155		-	another Penalty Group, a material, compound, mixture, or
156		-	preparation that contains any quantity of the following substances
157		-	having a potential for abuse associated with a depressant or
158		-	stimulant effect on the central nervous system:
159		-	Aminorex (some trade or other names: aminoxaphen;
160		-	2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
161		-	phenyl-2-oxazolamine);
162		-	Amphetamine, its salts, optical isomers, and
163		-	salts of optical isomers;
164		-	Cathinone (some trade or other names: 2-amino-1-
165		-	phenyl-1-propanone, alpha-aminopropiophenone, 2-
166		-	aminopropiophenone);
167		-	Etaqualone and its salts;
168		-	Etorphine Hydrochloride;
169		-	Fenethylline and its salts;
170		-	Lisdexamfetamine, including its salts, isomers,
171		-	and salts of isomers;
172		-	Mecloqualone and its salts;
173		-	Methaqualone and its salts;
174		-	Methcathinone (some trade or other names: 2-
175		-	methylamino-propiophenone; alpha-(methylamino)propriophenone;
176		-	2-(methylamino)-1-phenylpropan-1-one; alpha-N-
177		-	methylaminopropriophenone; monomethylpropion; ephedrone, N-
178		-	methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
179		-	1431);
180		-	N-Ethylamphetamine, its salts, optical isomers,
181		-	and salts of optical isomers; and
182		-	N,N-dimethylamphetamine (some trade or other
183		-	names: N,N,alpha-trimethylbenzeneethaneamine;
184		-	N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
185		-	and salts of optical isomers; and
186		-	(4) any compound structurally derived from
187		-	2-aminopropanal by substitution at the 1-position with any
188		-	monocyclic or fused-polycyclic ring system, including:
189		-	(A) compounds further modified by:
190		-	(i) substitution in the ring system to any
191		-	extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl,
192		-	hydroxyl, or halide substituents), whether or not further
193		-	substituted in the ring system by other substituents;
194		-	(ii) substitution at the 3-position with an
195		-	acyclic alkyl substituent; or
196		-	(iii) substitution at the 2-amino nitrogen
197		-	atom with alkyl, [or] dialkyl, benzyl, or methoxybenzyl groups, or
198		-	inclusion of the 2-amino nitrogen atom in a cyclic structure; and
199		-	(B) by example, compounds such as:
200		-	4-Methoxymethcathinone (Also known as
201		-	Methedrone);
202		-	4-Methylmethcathinone (Also known as
203		-	Mephedrone);
204		-	3,4-Dimethylmethcathinone (Also known as
205		-	3,4-DMMC);
206		-	3-Fluoromethcathinone (Also known as 3-FMC);
207		-	4-Fluoromethcathinone (Also known as
208		-	Flephedrone);
209		-	3,4-Methylenedioxy-N-methylcathinone (Also
210		-	known as Methylone);
211		-	3,4-Methylenedioxypyrovalerone (Also known
212		-	as MDPV);
213		-	alpha-Pyrrolidinopentiophenone (Also known
214		-	as alpha-PVP);
215		-	Naphthylpyrovalerone (Also known as
216		-	Naphyrone);
217		-	beta-Keto-N-methylbenzodioxolylpropylamine
218		-	(Also known as Butylone);
219		-	beta-Keto-N-methylbenzodioxolylpentanamine
220		-	(Also known as Pentylone);
221		-	beta-Keto-Ethylbenzodioxolylbutanamine
222		-	(Also known as Eutylone); and
223		-	3,4-methylenedioxy-N-ethylcathinone (Also
224		-	known as Ethylone).
225		-	SECTION 3. Section 481.1031, Health and Safety Code, is
226		-	amended to read as follows:
227		-	Sec. 481.1031. PENALTY GROUP 2-A. Penalty Group 2-A
228		-	consists of any quantity of a synthetic chemical compound that is a
229		-	cannabinoid receptor agonist and mimics the pharmacological effect
230		-	of naturally occurring cannabinoids, including:
231		-	naphthoylindoles structurally derived from
232		-	3-(1-naphthoyl)indole with or without [by] substitution at the
233		-	nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl,
234		-	cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
235		-	methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
236		-	(tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
237		-	or 2-(4-morpholinyl)ethyl, whether or not further substituted in
238		-	the indole ring to any extent, whether or not substituted in the
239		-	napthyl ring to any extent, including:
240		-	AM-2201;
241		-	JWH-004;
242		-	JWH-007;
243		-	JWH-009;
244		-	JWH-015;
245		-	JWH-016;
246		-	JWH-018;
247		-	JWH-019;
248		-	JWH-020;
249		-	JWH-046;
250		-	JWH-047;
251		-	JWH-048;
252		-	JWH-049;
253		-	JWH-050;
254		-	JWH-073;
255		-	JWH-076;
256		-	JWH-079;
257		-	JWH-080;
258		-	JWH-081;
259		-	JWH-082;
260		-	JWH-083;
261		-	JWH-093;
262		-	JWH-094;
263		-	JWH-095;
264		-	JWH-096;
265		-	JWH-097;
266		-	JWH-098;
267		-	JWH-099;
268		-	JWH-100;
269		-	JWH-116;
270		-	JWH-122;
271		-	JWH-148;
272		-	JWH-149;
273		-	JWH-153;
274		-	JWH-159;
275		-	JWH-164;
276		-	JWH-165;
277		-	JWH-166;
278		-	JWH-180;
279		-	JWH-181;
280		-	JWH-182;
281		-	JWH-189;
282		-	JWH-193;
283		-	JWH-198;
284		-	JWH-200;
285		-	JWH-210;
286		-	JWH-211;
287		-	JWH-212;
288		-	JWH-213;
289		-	JWH-234;
290		-	JWH-235;
291		-	JWH-239;
292		-	JWH-240;
293		-	JWH-241;
294		-	JWH-242;
295		-	JWH-258;
296		-	JWH-259;
297		-	JWH-260;
298		-	JWH-262;
299		-	JWH-267;
300		-	JWH-386;
301		-	JWH-387;
302		-	JWH-394;
303		-	JWH-395;
304		-	JWH-397;
305		-	JWH-398;
306		-	JWH-399;
307		-	JWH-400;
308		-	JWH-412;
309		-	JWH-413; and
310		-	JWH-414;
311		-	naphthylmethylindones structurally derived from
312		-	1H-indol-3-yl-(1-naphthyl)methane with or without [by]
313		-	substitution at the nitrogen atom of the indole ring by alkyl,
314		-	haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
315		-	(N-methylpiperidin-2-yl)methyl, cyanoalkyl, (N-methylpyrrolidin-
316		-	2-yl)methyl, (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-
317		-	morpholinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not
318		-	further substituted in the indole ring to any extent, whether or not
319		-	substituted in the naphthyl ring to any extent, including:
320		-	JWH-175;
321		-	JWH-184;
322		-	JWH-185;
323		-	JWH-192;
324		-	JWH-194;
325		-	JWH-195;
326		-	JWH-196;
327		-	JWH-197; and
328		-	JWH-199;
329		-	naphthoylpyrroles structurally derived from
330		-	3-(1-naphthoyl)pyrrole with or without [by] substitution at the
331		-	nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl,
332		-	cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
333		-	methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
334		-	(tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
335		-	or 2-(4-morpholinyl)ethyl, whether or not further substituted in
336		-	the pyrrole ring to any extent, whether or not substituted in the
337		-	naphthyl ring to any extent, including:
338		-	JWH-030;
339		-	JWH-145;
340		-	JWH-146;
341		-	JWH-147;
342		-	JWH-150;
343		-	JWH-156;
344		-	JWH-243;
345		-	JWH-244;
346		-	JWH-245;
347		-	JWH-246;
348		-	JWH-292;
349		-	JWH-293;
350		-	JWH-307;
351		-	JWH-308;
352		-	JWH-309;
353		-	JWH-346;
354		-	JWH-347;
355		-	JWH-348;
356		-	JWH-363;
357		-	JWH-364;
358		-	JWH-365;
359		-	JWH-366;
360		-	JWH-367;
361		-	JWH-368;
362		-	JWH-369;
363		-	JWH-370;
364		-	JWH-371;
365		-	JWH-372;
366		-	JWH-373; and
367		-	JWH-392;
368		-	naphthylmethylindenes structurally derived from
369		-	1-(1-naphthylmethyl)indene with or without [by] substitution at
370		-	the 3-position of the indene ring by alkyl, haloalkyl, alkenyl,
371		-	cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
372		-	methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
373		-	(tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
374		-	or 2-(4-morpholinyl)ethyl, whether or not further substituted in
375		-	the indene ring to any extent, whether or not substituted in the
376		-	naphthyl ring to any extent, including:
377		-	JWH-171;
378		-	JWH-172;
379		-	JWH-173; and
380		-	JWH-176;
381		-	phenylacetylindoles structurally derived from
382		-	3-phenylacetylindole with or without [by] substitution at the
383		-	nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl,
384		-	cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
385		-	methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
386		-	(tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
387		-	or 2-(4-morpholinyl)ethyl, whether or not further substituted in
388		-	the indole ring to any extent, whether or not substituted in the
389		-	phenyl ring to any extent, including:
390		-	AM-694;
391		-	AM-1241;
392		-	JWH-167;
393		-	JWH-203;
394		-	JWH-204;
395		-	JWH-205;
396		-	JWH-206;
397		-	JWH-208;
398		-	JWH-237;
399		-	JWH-248;
400		-	JWH-249;
401		-	JWH-250;
402		-	JWH-251;
403		-	JWH-252;
404		-	JWH-253;
405		-	JWH-302;
406		-	JWH-303;
407		-	JWH-305;
408		-	JWH-306;
409		-	JWH-311;
410		-	JWH-312;
411		-	JWH-313;
412		-	JWH-314; and
413		-	JWH-315;
414		-	cyclohexylphenols structurally derived from
415		-	2-(3-hydroxycyclohexyl)phenol with or without [by] substitution at
416		-	the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl,
417		-	cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
418		-	methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
419		-	(tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
420		-	or 2-(4-morpholinyl)ethyl, whether or not substituted in the
421		-	cyclohexyl ring to any extent, including:
422		-	CP-55,940;
423		-	CP-47,497;
424		-	analogues of CP-47,497, including VII, V, VIII, I,
425		-	II, III, IV, IX, X, XI, XII, XIII, XV, and XVI;
426		-	JWH-337;
427		-	JWH-344;
428		-	JWH-345; and
429		-	JWH-405; [and]
430		-	benzoylindoles structurally derived from
431		-	3-(1-naphthoyl)indole with or without substitution at the nitrogen
432		-	atom of the indole ring with alkyl, haloalkyl, alkenyl,
433		-	cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
434		-	methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
435		-	(tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
436		-	or 2-(4-morpholinyl)ethyl, whether or not further substituted in
437		-	the indole ring to any extent, whether or not substituted in the
438		-	phenyl ring to any extent, including:
439		-	1-pentyl-3-(4-methoxybenzoyl)indole (RCS-4); and
440		-	1-[2-(4-morpholinyl)ethyl]-2-methyl-3-(4-
441		-	methoxybenzoyl)indole (Pravadoline or WIN 48,098); and
442		-	cannabinol derivatives, except where contained in
443		-	marihuana, including tetrahydro derivatives of cannabinol and
444		-	3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
445		-	such as:
446		-	Nabilone;
447		-	HU-210;
448		-	HU-211; and
449		-	WIN-55,212-2.
450		-	SECTION 4. Section 481.106, Health and Safety Code, is
451		-	amended to read as follows:
452		-	Sec. 481.106. CLASSIFICATION OF CONTROLLED SUBSTANCE
453		-	ANALOGUE. For the purposes of the prosecution of an offense under
454		-	this subchapter involving the manufacture, delivery, or possession
455		-	of a controlled substance, Penalty Groups 1, 1-A, [and] 2, and 2-A
456		-	include a controlled substance analogue that:
457		-	(1) has a chemical structure substantially similar to
458		-	the chemical structure of a controlled substance listed in the
459		-	applicable penalty group; or
460		-	(2) is specifically designed to produce an effect
461		-	substantially similar to, or greater than, a controlled substance
462		-	listed in the applicable penalty group.
463		-	SECTION 5. Section 481.119(a), Health and Safety Code, is
	8	+	SECTION 1. Section 481.119(a), Health and Safety Code, is
464	9		amended to read as follows:
465	10		(a) A person commits an offense if the person knowingly
466	11		manufactures, delivers, or possesses with intent to deliver a
467	12		controlled substance listed in a schedule by an action of the
468	13		commissioner under this chapter but not listed in a penalty group.
469	14		An offense under this subsection is a Class A misdemeanor, except
470	15		that the offense is:
471	16		(1) a state jail felony, if the person has been
472	17		previously convicted of an offense under this subsection; or
473	18		(2) a felony of the third degree, if the person has
474	19		been previously convicted two or more times of an offense under this
475	20		subsection.
476		-	SECTION 6. The changes in law made by this Act apply only to
477		-	an offense committed on or after the effective date of this Act. An
478		-	offense committed before the effective date of this Act is governed
479		-	by the law in effect on the date the offense was committed, and the
480		-	former law is continued in effect for that purpose. For purposes of
481		-	this section, an offense was committed before the effective date of
482		-	this Act if any element of the offense occurred before that date.
483		-	SECTION 7. This Act takes effect September 1, 2015.
	21	+	SECTION 2. The change in law made by this Act applies only
	22	+	to an offense committed on or after the effective date of this Act.
	23	+	An offense committed before the effective date of this Act is
	24	+	governed by the law in effect on the date the offense was committed,
	25	+	and the former law is continued in effect for that purpose. For
	26	+	purposes of this section, an offense was committed before the
	27	+	effective date of this Act if any element of the offense occurred
	28	+	before that date.
	29	+	SECTION 3. This Act takes effect September 1, 2015.
	30	+	______________________________ ______________________________
	31	+	President of the Senate Speaker of the House
	32	+	I certify that H.B. No. 1424 was passed by the House on May
	33	+	12, 2015, by the following vote: Yeas 145, Nays 0, 2 present, not
	34	+	voting; and that the House concurred in Senate amendments to H.B.
	35	+	No. 1424 on May 29, 2015, by the following vote: Yeas 144, Nays 1,
	36	+	2 present, not voting.
	37	+	______________________________
	38	+	Chief Clerk of the House
	39	+	I certify that H.B. No. 1424 was passed by the Senate, with
	40	+	amendments, on May 27, 2015, by the following vote: Yeas 31, Nays
	41	+	0.
	42	+	______________________________
	43	+	Secretary of the Senate
	44	+	APPROVED: __________________
	45	+	Date
	46	+	__________________
	47	+	Governor